Qualification of Drivers; Exemption Applications; Diabetes Mellitus, 24303-24304 [2013-09688]
Download as PDF
Federal Register / Vol. 78, No. 79 / Wednesday, April 24, 2013 / Notices
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[FMCSA Docket No. FMCSA–2013–0013]
Qualification of Drivers; Exemption
Applications; Diabetes Mellitus
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
AGENCY:
FMCSA announces its
decision to exempt 25 individuals from
its rule prohibiting persons with
insulin-treated diabetes mellitus (ITDM)
from operating commercial motor
vehicles (CMVs) in interstate commerce.
The exemptions will enable these
individuals to operate CMVs in
interstate commerce.
DATES: The exemptions are effective
April 24, 2013. The exemptions expire
on April 24, 2015.
FOR FURTHER INFORMATION CONTACT:
Elaine M. Papp, Chief, Medical
Programs Division, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA, Room
W64–224, Department of
Transportation, 1200 New Jersey
Avenue SE., Washington, DC 20590–
0001. Office hours are from 8:30 a.m. to
5 p.m., Monday through Friday, except
Federal holidays.
SUPPLEMENTARY INFORMATION:
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
Electronic Access
You may see all the comments online
through the Federal Document
Management System (FDMS) at: https://
www.regulations.gov.
Docket: For access to the docket to
read background documents or
comments, go to https://
www.regulations.gov and/or Room
W12–140 on the ground level of the
West Building, 1200 New Jersey Avenue
SE., Washington, DC, between 9 a.m.
and 5 p.m., Monday through Friday,
except Federal holidays.
Privacy Act: Anyone may search the
electronic form of all comments
received into any of DOT’s dockets by
the name of the individual submitting
the comment (or of the person signing
the comment, if submitted on behalf of
an association, business, labor union, or
other entity). You may review DOT’s
Privacy Act Statement for the Federal
Docket Management System (FDMS)
published in the Federal Register on
December 29, 2010 (75 FR 82132), or
you may visit https://www.gpo.gov/fdsys/
pkg/FR-2010-12-29/pdf/2010-32876.pdf.
Background
On March 5, 2013, FMCSA published
a notice of receipt of Federal diabetes
VerDate Mar<15>2010
18:05 Apr 23, 2013
Jkt 229001
exemption applications from 25
individuals and requested comments
from the public (78 FR 14406). The
public comment period closed on April
4, 2013, and one comment was received.
FMCSA has evaluated the eligibility
of the 25 applicants and determined that
granting the exemptions to these
individuals would achieve a level of
safety equivalent to or greater than the
level that would be achieved by
complying with the current regulation
49 CFR 391.41(b)(3).
Diabetes Mellitus and Driving
Experience of the Applicants
The Agency established the current
requirement for diabetes in 1970
because several risk studies indicated
that drivers with diabetes had a higher
rate of crash involvement than the
general population. The diabetes rule
provides that ‘‘A person is physically
qualified to drive a commercial motor
vehicle if that person has no established
medical history or clinical diagnosis of
diabetes mellitus currently requiring
insulin for control’’ (49 CFR
391.41(b)(3)).
FMCSA established its diabetes
exemption program, based on the
Agency’s July 2000 study entitled ‘‘A
Report to Congress on the Feasibility of
a Program to Qualify Individuals with
Insulin-Treated Diabetes Mellitus to
Operate in Interstate Commerce as
Directed by the Transportation Act for
the 21st Century.’’ The report concluded
that a safe and practicable protocol to
allow some drivers with ITDM to
operate CMVs is feasible. The
September 3, 2003 (68 FR 52441),
Federal Register notice in conjunction
with the November 8, 2005 (70 FR
67777), Federal Register notice provides
the current protocol for allowing such
drivers to operate CMVs in interstate
commerce.
These 25 applicants have had ITDM
over a range of 1 to 29 years. These
applicants report no severe
hypoglycemic reactions resulting in loss
of consciousness or seizure, requiring
the assistance of another person, or
resulting in impaired cognitive function
that occurred without warning
symptoms, in the past 12 months and no
recurrent (2 or more) severe
hypoglycemic episodes in the past 5
years. In each case, an endocrinologist
verified that the driver has
demonstrated a willingness to properly
monitor and manage his/her diabetes
mellitus, received education related to
diabetes management, and is on a stable
insulin regimen. These drivers report no
other disqualifying conditions,
including diabetes-related
PO 00000
Frm 00154
Fmt 4703
Sfmt 4703
24303
complications. Each meets the vision
requirement at 49 CFR 391.41(b)(10).
The qualifications and medical
condition of each applicant were stated
and discussed in detail in the March 5,
2013, Federal Register notice and they
will not be repeated in this notice.
Discussion of Comments
FMCSA received one comment in this
proceeding. The comment is considered
and discussed below.
The Pennsylvania Department of
Transportation is in favor of granting an
exemption to Scott A. Carlson after
reviewing his driving history.
Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315,
FMCSA may grant an exemption from
the diabetes requirement in 49 CFR
391.41(b)(3) if the exemption is likely to
achieve an equivalent or greater level of
safety than would be achieved without
the exemption. The exemption allows
the applicants to operate CMVs in
interstate commerce.
To evaluate the effect of these
exemptions on safety, FMCSA
considered medical reports about the
applicants’ ITDM and vision, and
reviewed the treating endocrinologists’
medical opinion related to the ability of
the driver to safely operate a CMV while
using insulin.
Consequently, FMCSA finds that in
each case exempting these applicants
from the diabetes requirement in 49 CFR
391.41(b)(3) is likely to achieve a level
of safety equal to that existing without
the exemption.
Conditions and Requirements
The terms and conditions of the
exemption will be provided to the
applicants in the exemption document
and they include the following: (1) That
each individual submit a quarterly
monitoring checklist completed by the
treating endocrinologist as well as an
annual checklist with a comprehensive
medical evaluation; (2) that each
individual reports within 2 business
days of occurrence, all episodes of
severe hypoglycemia, significant
complications, or inability to manage
diabetes; also, any involvement in an
accident or any other adverse event in
a CMV or personal vehicle, whether or
not it is related to an episode of
hypoglycemia; (3) that each individual
provide a copy of the ophthalmologist’s
or optometrist’s report to the medical
examiner at the time of the annual
medical examination; and (4) that each
individual provide a copy of the annual
medical certification to the employer for
retention in the driver’s qualification
file, or keep a copy in his/her driver’s
E:\FR\FM\24APN1.SGM
24APN1
24304
Federal Register / Vol. 78, No. 79 / Wednesday, April 24, 2013 / Notices
qualification file if he/she is selfemployed. The driver must also have a
copy of the certification when driving,
for presentation to a duly authorized
Federal, State, or local enforcement
official.
Conclusion
Based upon its evaluation of the 25
exemption applications, FMCSA
exempts Christopher R. Anderson (MN),
Brent T. Applebury (MO), Joseph A.
Auchterlonie (NH), Brett D. Bertagnolli
(IN), Brian T. Bofenkamp (WA), Scott A.
Carlson (PA), Craig L. Falck (WI), John
Fityere (NJ), Dana R. Griswold (VT),
Ronald A. Heaps (OH), Martin A. Houts
(IA), Michael T. Kraft (MN), Kris W.
Lindsay (KS), Edward M. Lucynski (NJ),
Wendell J. Matthews (MO), Patric L.
Patten (NH), Darryl G. Rockwell (TX),
John E. Ruth (IL), Greggory A. Smith
(MO), Dwight E. Sory (CO), James M.
Torklidson (WI), Terry R. Washa (NE),
Alfred J. Williams (VA), Scott B. Wood
(ND), and James L. Zore (IN) from the
ITDM requirement in 49 CFR
391.41(b)(3), subject to the conditions
listed under ‘‘Conditions and
Requirements’’ above.
In accordance with 49 U.S.C. 31136(e)
and 31315 each exemption will be valid
for two years unless revoked earlier by
FMCSA. The exemption will be revoked
if the following occurs: (1) The person
fails to comply with the terms and
conditions of the 1/exemption; (2) the
exemption has resulted in a lower level
of safety than was maintained before it
was granted; or (3) continuation of the
exemption would not be consistent with
the goals and objectives of 49 U.S.C.
31136(e) and 31315. If the exemption is
still effective at the end of the 2-year
period, the person may apply to FMCSA
for a renewal under procedures in effect
at that time.
Issued on: April 12, 2013.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2013–09688 Filed 4–23–13; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
tkelley on DSK3SPTVN1PROD with NOTICES
National Highway Traffic Safety
Administration
Petition for Exemption From the
Vehicle Theft Prevention Standard;
Maserati North America Inc.
National Highway Traffic
Safety Administration (NHTSA),
Department of Transportation (DOT).
AGENCY:
ACTION:
Grant of petition for exemption.
VerDate Mar<15>2010
18:05 Apr 23, 2013
Jkt 229001
This document grants in full
Maserati North America Inc.’s,
(Maserati) petition for an exemption of
the Quattroporte vehicle line in
accordance with 49 CFR Part 543,
Exemption from the Theft Prevention
Standard. This petition is granted
because the agency has determined that
the antitheft device to be placed on the
line as standard equipment is likely to
be as effective in reducing and deterring
motor vehicle theft as compliance with
the parts-marking requirements of the
Theft Prevention Standard (49 CFR Part
541).
DATES: The exemption granted by this
notice is effective beginning with the
2014 model year (MY).
FOR FURTHER INFORMATION CONTACT: Ms.
Carlita Ballard, Office of International
Policy, Fuel Economy and Consumer
Programs, NHTSA, W43–439, 1200 New
Jersey Avenue SE., Washington, DC
20590. Ms. Ballard’s phone number is
(202) 366–5222. Her fax number is (202)
493–2990.
SUPPLEMENTARY INFORMATION: In a
petition dated March 11, 2013, Maserati
requested an exemption from the partsmarking requirements of the Theft
Prevention Standard (49 CFR Part 541)
for the MY 2014 Quattroporte vehicle
line. The petition requested an
exemption from parts-marking pursuant
to 49 CFR Part 543, Exemption from
Vehicle Theft Prevention Standard,
based on the installation of an antitheft
device as standard equipment for an
entire vehicle line.
Under § 543.5(a), a manufacturer may
petition NHTSA to grant an exemption
for one vehicle line per model year. In
its petition, Maserati provided a
detailed description and diagram of the
identity, design, and location of the
components of the antitheft device for
the Quattroporte vehicle line. Maserati
stated that all of its vehicles will be
equipped with a passive, Sentry Key
Immobilizer System (SKIS), a Vehicle
Alarm System (VTA) and a Keyless
Ignition System as standard equipment
beginning with the 2014 model year.
Key components of its SKIS antitheft
device will include an Engine Power
Control Module (ECM), Fuel Delivery,
Starter Motor Circuit, and a Shaft Lock
Module. Maserati’s keyless ignition
system will consist of a Key Fob with
Remote Keyless Entry (RKE)
Transmitter, RFHub and Keyless
Ignition Node (KIN). Maserati will
provide its VTA system as standard
equipment. The VTA will provide
perimeter protection by monitoring the
vehicle doors, ignition switch and deck
lid. The VTA alarm system includes an
ultrasonic sensor to defeat motion
SUMMARY:
PO 00000
Frm 00155
Fmt 4703
Sfmt 4703
within the vehicle and has the ability to
be armed without the intrusion sensor.
Maserati stated that if unauthorized
tampering with any of these protected
areas is detected, the system will
respond by pulsing the vehicle’s horn/
siren as an audible deterrent and
flashing certain exterior lamps as a
visual deterrent. Maserati’s submission
is considered a complete petition as
required by 49 CFR 543.7, in that it
meets the general requirements
contained in § 543.5 and the specific
content requirements of § 543.6.
Maserati stated that the immobilizer
device is automatically armed when the
ignition is changed from the run
position to the off position. Once
activated, only the use of a valid key can
disable immobilization and allow the
vehicle to run. Specifically, Maserati
stated that the device is disarmed by
performing an unlock actuation via the
RKE transmitter or by starting the
vehicle with a valid RFHub key.
Maserati stated that to start the vehicle,
the driver must press and hold the brake
pedal while pressing the START/STOP
button. The system takes over and
engages the starter causing the starter
motor to run and disengage
automatically when the engine is
running. Maserati stated that the RFHub
contains and controls the SKIS
preventing unauthorized use of the
vehicle by preventing the engine from
running more than 2 seconds unless a
valid FOBIK key is used to start the
engine. Maserati also stated that the
vehicle’s key fob with RKE transmitter,
RFHub and the KIN contains over
50,000 possible electronic key
combinations and allows the driver to
operate the ignition switch with the
push of a button as long as the RKE
transmitter is in the passenger
compartment.
In addressing the specific content
requirements of 543.6, Maserati
provided information on the reliability
and durability of its proposed device.
To ensure reliability and durability of
the device, Maserati conducted tests
based on its own specified standards.
Maserati provided a detailed list of the
tests conducted (i.e., temperature and
humidity cycling, high and low
temperature cycling, mechanical shock,
random vibration, thermal stress/shock
tests, material resistance tests, dry heat,
dust and fluid ingress tests). Maserati
also stated that the VTA, including the
immobilizer device and its related
components, must meet design and
durability requirements for full vehicle
useful life (10 years/120k miles).
Maserati stated that it believes that its
device is reliable and durable because it
E:\FR\FM\24APN1.SGM
24APN1
Agencies
[Federal Register Volume 78, Number 79 (Wednesday, April 24, 2013)]
[Notices]
[Pages 24303-24304]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-09688]
[[Page 24303]]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[FMCSA Docket No. FMCSA-2013-0013]
Qualification of Drivers; Exemption Applications; Diabetes
Mellitus
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces its decision to exempt 25 individuals from its
rule prohibiting persons with insulin-treated diabetes mellitus (ITDM)
from operating commercial motor vehicles (CMVs) in interstate commerce.
The exemptions will enable these individuals to operate CMVs in
interstate commerce.
DATES: The exemptions are effective April 24, 2013. The exemptions
expire on April 24, 2015.
FOR FURTHER INFORMATION CONTACT: Elaine M. Papp, Chief, Medical
Programs Division, (202) 366-4001, fmcsamedical@dot.gov, FMCSA, Room
W64-224, Department of Transportation, 1200 New Jersey Avenue SE.,
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m.,
Monday through Friday, except Federal holidays.
SUPPLEMENTARY INFORMATION:
Electronic Access
You may see all the comments online through the Federal Document
Management System (FDMS) at: https://www.regulations.gov.
Docket: For access to the docket to read background documents or
comments, go to https://www.regulations.gov and/or Room W12-140 on the
ground level of the West Building, 1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.
Privacy Act: Anyone may search the electronic form of all comments
received into any of DOT's dockets by the name of the individual
submitting the comment (or of the person signing the comment, if
submitted on behalf of an association, business, labor union, or other
entity). You may review DOT's Privacy Act Statement for the Federal
Docket Management System (FDMS) published in the Federal Register on
December 29, 2010 (75 FR 82132), or you may visit https://www.gpo.gov/fdsys/pkg/FR-2010-12-29/pdf/2010-32876.pdf.
Background
On March 5, 2013, FMCSA published a notice of receipt of Federal
diabetes exemption applications from 25 individuals and requested
comments from the public (78 FR 14406). The public comment period
closed on April 4, 2013, and one comment was received.
FMCSA has evaluated the eligibility of the 25 applicants and
determined that granting the exemptions to these individuals would
achieve a level of safety equivalent to or greater than the level that
would be achieved by complying with the current regulation 49 CFR
391.41(b)(3).
Diabetes Mellitus and Driving Experience of the Applicants
The Agency established the current requirement for diabetes in 1970
because several risk studies indicated that drivers with diabetes had a
higher rate of crash involvement than the general population. The
diabetes rule provides that ``A person is physically qualified to drive
a commercial motor vehicle if that person has no established medical
history or clinical diagnosis of diabetes mellitus currently requiring
insulin for control'' (49 CFR 391.41(b)(3)).
FMCSA established its diabetes exemption program, based on the
Agency's July 2000 study entitled ``A Report to Congress on the
Feasibility of a Program to Qualify Individuals with Insulin-Treated
Diabetes Mellitus to Operate in Interstate Commerce as Directed by the
Transportation Act for the 21st Century.'' The report concluded that a
safe and practicable protocol to allow some drivers with ITDM to
operate CMVs is feasible. The September 3, 2003 (68 FR 52441), Federal
Register notice in conjunction with the November 8, 2005 (70 FR 67777),
Federal Register notice provides the current protocol for allowing such
drivers to operate CMVs in interstate commerce.
These 25 applicants have had ITDM over a range of 1 to 29 years.
These applicants report no severe hypoglycemic reactions resulting in
loss of consciousness or seizure, requiring the assistance of another
person, or resulting in impaired cognitive function that occurred
without warning symptoms, in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the past 5 years. In each case,
an endocrinologist verified that the driver has demonstrated a
willingness to properly monitor and manage his/her diabetes mellitus,
received education related to diabetes management, and is on a stable
insulin regimen. These drivers report no other disqualifying
conditions, including diabetes-related complications. Each meets the
vision requirement at 49 CFR 391.41(b)(10).
The qualifications and medical condition of each applicant were
stated and discussed in detail in the March 5, 2013, Federal Register
notice and they will not be repeated in this notice.
Discussion of Comments
FMCSA received one comment in this proceeding. The comment is
considered and discussed below.
The Pennsylvania Department of Transportation is in favor of
granting an exemption to Scott A. Carlson after reviewing his driving
history.
Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the diabetes requirement in 49 CFR 391.41(b)(3) if the exemption
is likely to achieve an equivalent or greater level of safety than
would be achieved without the exemption. The exemption allows the
applicants to operate CMVs in interstate commerce.
To evaluate the effect of these exemptions on safety, FMCSA
considered medical reports about the applicants' ITDM and vision, and
reviewed the treating endocrinologists' medical opinion related to the
ability of the driver to safely operate a CMV while using insulin.
Consequently, FMCSA finds that in each case exempting these
applicants from the diabetes requirement in 49 CFR 391.41(b)(3) is
likely to achieve a level of safety equal to that existing without the
exemption.
Conditions and Requirements
The terms and conditions of the exemption will be provided to the
applicants in the exemption document and they include the following:
(1) That each individual submit a quarterly monitoring checklist
completed by the treating endocrinologist as well as an annual
checklist with a comprehensive medical evaluation; (2) that each
individual reports within 2 business days of occurrence, all episodes
of severe hypoglycemia, significant complications, or inability to
manage diabetes; also, any involvement in an accident or any other
adverse event in a CMV or personal vehicle, whether or not it is
related to an episode of hypoglycemia; (3) that each individual provide
a copy of the ophthalmologist's or optometrist's report to the medical
examiner at the time of the annual medical examination; and (4) that
each individual provide a copy of the annual medical certification to
the employer for retention in the driver's qualification file, or keep
a copy in his/her driver's
[[Page 24304]]
qualification file if he/she is self-employed. The driver must also
have a copy of the certification when driving, for presentation to a
duly authorized Federal, State, or local enforcement official.
Conclusion
Based upon its evaluation of the 25 exemption applications, FMCSA
exempts Christopher R. Anderson (MN), Brent T. Applebury (MO), Joseph
A. Auchterlonie (NH), Brett D. Bertagnolli (IN), Brian T. Bofenkamp
(WA), Scott A. Carlson (PA), Craig L. Falck (WI), John Fityere (NJ),
Dana R. Griswold (VT), Ronald A. Heaps (OH), Martin A. Houts (IA),
Michael T. Kraft (MN), Kris W. Lindsay (KS), Edward M. Lucynski (NJ),
Wendell J. Matthews (MO), Patric L. Patten (NH), Darryl G. Rockwell
(TX), John E. Ruth (IL), Greggory A. Smith (MO), Dwight E. Sory (CO),
James M. Torklidson (WI), Terry R. Washa (NE), Alfred J. Williams (VA),
Scott B. Wood (ND), and James L. Zore (IN) from the ITDM requirement in
49 CFR 391.41(b)(3), subject to the conditions listed under
``Conditions and Requirements'' above.
In accordance with 49 U.S.C. 31136(e) and 31315 each exemption will
be valid for two years unless revoked earlier by FMCSA. The exemption
will be revoked if the following occurs: (1) The person fails to comply
with the terms and conditions of the 1/exemption; (2) the exemption has
resulted in a lower level of safety than was maintained before it was
granted; or (3) continuation of the exemption would not be consistent
with the goals and objectives of 49 U.S.C. 31136(e) and 31315. If the
exemption is still effective at the end of the 2-year period, the
person may apply to FMCSA for a renewal under procedures in effect at
that time.
Issued on: April 12, 2013.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2013-09688 Filed 4-23-13; 8:45 am]
BILLING CODE 4910-EX-P